These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 9527656)
1. [Therapeutic effect of zuclopenthixol acetate on positive and negative symptoms in schizophrenia]. Szafrański T; Jarema M; Białek J; Buksowicz M; Marciniak E; Choma ME; Ruzikowska A; Milej M Psychiatr Pol; 1997; 31(1):55-69. PubMed ID: 9527656 [TBL] [Abstract][Full Text] [Related]
2. [Efficacy of zuclopenthixol acetate on psychotic anxiety evaluated in an open study]. Romain JL; Dermain P; Greslé P; Grignon S; Moisan P; Nore D; Pech G; Benyaya J; Perret I Encephale; 1996; 22(4):280-6. PubMed ID: 9035983 [TBL] [Abstract][Full Text] [Related]
3. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation. Chouinard G; Safadi G; Beauclair L J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017 [TBL] [Abstract][Full Text] [Related]
4. A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics. Chin CN; Hamid AR; Philip G; Ramlee T; Mahmud M; Zulkifli G; Loh CC; Zakariah MS; Norhamidah MS; Suraya Y; Roslan KA; Chandramohan P; Cheah YC; Leonard AO Med J Malaysia; 1998 Dec; 53(4):365-71. PubMed ID: 10971979 [TBL] [Abstract][Full Text] [Related]
5. An open study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses. Fend I; Jochum W; Eberhardt G; König P Schizophr Res; 1988; 1(5):359-61. PubMed ID: 2908705 [No Abstract] [Full Text] [Related]
6. Zuclopenthixol acetate in viscoleo in acutely disturbed psychotic patients. Schlosberg A; Barr F Isr J Psychiatry Relat Sci; 1991; 28(2):60-3. PubMed ID: 1682290 [TBL] [Abstract][Full Text] [Related]
7. Effects of low-dose risperidone and low-dose zuclopenthixol on cognitive functions in first-episode drug-naive schizophrenic patients. Fagerlund B; Mackeprang T; Gade A; Glenthøj BY CNS Spectr; 2004 May; 9(5):364-74. PubMed ID: 15115949 [TBL] [Abstract][Full Text] [Related]
8. [Acute schizophrenia concept and definition: investigation of a French psychiatrist population]. Baylé FJ; Misdrahi D; Llorca PM; Lançon C; Olivier V; Quintin P; Azorin JM Encephale; 2005; 31(1 Pt 1):10-7. PubMed ID: 15971635 [TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation and serum concentration of zuclopenthixol acetate in psychotic Asian patients: a single-dose preliminary study. Tan CH; Low BL; Ng LL; Khoo YM; Lee HS Ther Drug Monit; 1993 Apr; 15(2):108-12. PubMed ID: 8099240 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of three different injectable zuclopenthixol preparations. Aaes-Jørgensen T Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):77-85. PubMed ID: 2568662 [TBL] [Abstract][Full Text] [Related]
11. Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales. Bobon D; Troisfontaines B; Kempeneers JL; Xhenseval B; Bourdouxhe S; Mirel J; Gilson H; Toussaint C; von Frenckell R; Pedersen V Acta Psychiatr Belg; 1986; 86(2):152-76. PubMed ID: 2873713 [TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of zuclopenthixol acetate compared with injectable haloperidol in schizophrenic patients with acute psychosis. Laurier C; Kennedy W; Lachaine J; Gariepy L; Tessier G Clin Ther; 1997; 19(2):316-29. PubMed ID: 9152570 [TBL] [Abstract][Full Text] [Related]
13. A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate. Carney MW Pharmatherapeutica; 1984; 4(1):57-63. PubMed ID: 6150493 [TBL] [Abstract][Full Text] [Related]
14. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study. Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129 [TBL] [Abstract][Full Text] [Related]
15. Zuclopenthixol: a new generation of antipsychotic drugs. An open clinical trial. Matar AM; Abdel-Mawgoud M; Skov S J Clin Psychopharmacol; 1990 Aug; 10(4):283-6. PubMed ID: 1981068 [TBL] [Abstract][Full Text] [Related]
16. Clopenthixol decanoate in schizophrenia. Carney MW; Rutherford P Curr Med Res Opin; 1981; 7(4):205-11. PubMed ID: 6112116 [TBL] [Abstract][Full Text] [Related]
17. Serum concentrations and clinical effect of zuclopenthixol in acutely disturbed, psychotic patients treated with zuclopenthixol acetate in Viscoleo. Amdisen A; Aaes-Jørgensen T; Thomsen NJ; Madsen VT; Nielsen MS Psychopharmacology (Berl); 1986; 90(3):412-6. PubMed ID: 2878462 [TBL] [Abstract][Full Text] [Related]
18. Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype. Jaanson P; Marandi T; Kiivet RA; Vasar V; Vään S; Svensson JO; Dahl ML Psychopharmacology (Berl); 2002 Jun; 162(1):67-73. PubMed ID: 12107620 [TBL] [Abstract][Full Text] [Related]
19. Zuclopenthixol acetate (5% in 'Viscoleo'): single-dose treatment for acutely disturbed psychotic patients. Chakravarti SK; Muthu A; Muthu PK; Naik P; Pinto RT Curr Med Res Opin; 1990; 12(1):58-65. PubMed ID: 1971560 [TBL] [Abstract][Full Text] [Related]
20. Zuclopenthixol acetate in Viscoleo--a new drug formulation. An open Nordic multicentre study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses including mania and exacerbation of chronic psychoses. Amdisen A; Nielsen MS; Dencker SJ; Fensbo C; Ahlfors UG; Gravem A; Baastrup PC; Bjerkenstedt L; Gunby B; Wiesel FA Acta Psychiatr Scand; 1987 Jan; 75(1):99-107. PubMed ID: 2883816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]